Immunomodulation therapy offers new molecular strategies to treat UTI.

Butler, Daniel; Ambite, Ines; Wan, Murphy Lam Yim; Tran, Thi Hien; Wullt, Björn; Svanborg, Catharina

Butler, Daniel; Ambite, Ines; Wan, Murphy Lam Yim; Tran, Thi Hien; Wullt, Björn; Svanborg, Catharina.

Afiliação

Butler D; Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.
Ambite I; Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.
Wan MLY; Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.
Tran TH; Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.
Wullt B; Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.
Svanborg C; Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden. catharina.svanborg@med.lu.se.

Nat Rev Urol ; 19(7): 419-437, 2022 07.

Article em En | MEDLINE | ID: mdl-35732832

Assuntos

Cistite; Pielonefrite; Infecções Urinárias; Antibacterianos/uso terapêutico; Cistite/tratamento farmacológico; Humanos; Imunomodulação; Pielonefrite/tratamento farmacológico; Pielonefrite/genética; Pielonefrite/microbiologia; Infecções Urinárias/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pielonefrite / Infecções Urinárias / Cistite Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google